Farther Finance Advisors »

Zentalis Pharmaceuticals shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $37 10 3.70
2024-06-30 $42 10 4.20
2024-03-31 $161 10 16.10
2023-12-31 $152 10 15.20

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Microsoft Corp Stock (MSFT)
Uva Unconstrained Medium-term Fixed Income Etf Etf (FFIU)
Ishares National Muni Bond Etf Etf (MUB)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Amazon Stock (AMZN)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares S&p 500 Growth Etf Etf (IVW)

View all positions for Farther Finance Advisors

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Eventide Asset Management
Vanguard Group
BlackRock
BlackRock
Decheng Capital
State Street Corporation
Citadel Advisors
Morgan Stanley
PRIMECAP Management Company
MPM Oncology Impact Management
Geode Capital Management
D. E. Shaw & Co
Woodline Partners
Two Sigma Investments

View all funds holding Zentalis Pharmaceuticals